Billing Details
Report Name
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis
Shopping Cart
Report Id | License Type | Price |
---|---|---|
Total | $ 2995 |